Table 3 Summary of concomitant medication reported by pregnant women in PREGACT trial
Concomitant medication | Number of times reportedb, n(%) | Number of patientsa, n(%) |
|---|---|---|
Iron supplement | 869 (26.3) | 856 (99.2) |
Paracetamol | 864 (26.2) | 520 (60.3) |
Others | 433 (13.1) | 302 (35.0) |
Albendazole | 353 (10.7) | 353 (40.9) |
Amoxicillin | 220 (6.7) | 192 (22.3) |
Benzathine | 108 (3.3) | 68 (7.9) |
Pethidine | 49 (1.5) | 49 (5.7) |
Chloramphenicol | 48 (1.5) | 43 (5.0) |
Oral Rehydration Salts (ORS) | 47 (1.4) | 44 (5.1) |
Dextrose | 47 (1.4) | 45 (5.2) |
Lignocaine | 39 (1.2) | 39 (4.5) |
Metronidazole | 38 (1.2) | 36 (4.3) |
Quinine | 35 (1.1) | 26 (3.0) |
Gentamycin | 35 (1.1) | 35 (4.1) |
Sulfadoxine-Pyrimethamine | 31 (0.9) | 27 (3.1) |
Aspirin | 16 (0.5) | 14 (1.6) |
Pitocin | 16 (0.5) | 16 (1.9) |
Erythromycin | 13 (0.4) | 12 (1.4) |
Piriton | 12 (0.4) | 12 (1.4) |
Methyldopa | 12 (0.4) | 9 (1.0) |
Cotrimoxazole | 8 (0.2) | 8 (0.9) |
Promethazine | 7 (0.2) | 7 (0.8) |
Multivitamin Tabs | 4 (0.1) | 3 (0.4) |